SC
RMD icon

Savant Capital’s ResMed RMD Stock Holding History

Savant Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.54M Buy
7,308
+2,684
+58% +$556K ﹤0.01% 698
2026
Q1 		$1.04M Buy
4,624
+411
+10% +$102K 0.01% 620
2025
Q4 		$1.01M Sell
4,213
-122
-3% -$31.2K 0.01% 576
2025
Q3 		$1.19M Sell
4,335
-9
-0.2% -$2.46K 0.01% 518
2025
Q2 		$1.12M Buy
4,344
+473
+12% +$113K 0.01% 488
2025
Q1 		$867K Sell
3,871
-6,925
-64% -$1.62M 0.01% 517
2024
Q4 		$2.47M Buy
10,796
+487
+5% +$117K 0.02% 388
2024
Q3 		$2.52M Buy
10,309
+7,501
+267% +$1.68M 0.02% 360
2024
Q2 		$538K Sell
2,808
-6,271
-69% -$1.27M 0.01% 771
2024
Q1 		$1.8M Buy
9,079
+5,827
+179% +$1.07M 0.02% 385
2023
Q4 		$559K Sell
3,252
-372
-10% -$57.2K 0.01% 539
2023
Q3 		$536K Buy
3,624
+17
+0.5% +$3.07K 0.01% 508
2023
Q2 		$788K Buy
3,607
+2,649
+277% +$590K 0.01% 425
2023
Q1 		$210K Buy
+958
New +$208K ﹤0.01% 676

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Savant Capital's RMD Position: Q2 2026 in Review

Savant Capital increased its ResMed (RMD) stake by 58% in Q2 2026, buying an estimated $556K and bringing the position to 7,308 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #698.

Savant Capital first reported a position in RMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.52M in Q3 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Savant Capital held 7,308 shares of ResMed worth $1.54M as of Q2 2026.
  • Savant Capital bought 2,684 ResMed shares in Q2 2026, an estimated $556K.
  • ResMed made up ﹤0.01% of Savant Capital's portfolio in Q2 2026, its #698 holding.
  • Savant Capital first reported a position in ResMed in Q1 2023 and has held it in 14 quarters since.
  • Savant Capital's ResMed position peaked at $2.52M in Q3 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.